Showing results (181-190 of 201) with videos related to

Sort By:
Pageof 21
Frontiers in Immunology|April 2, 2021
Activation of Neutrophil Granulocytes by Platelet-Activating Factor Is Impaired During Experimental SepsisStefan Hug, Stefan Bernhard, Alexander Elias Paul Stratmann, et al.
Fluids and Barriers of the CNS|October 28, 2024
[11C]Metoclopramide PET can detect a seizure-induced up-regulation of cerebral P-glycoprotein in epilepsy patientsMyriam El Biali, Louise Breuil, Matthias Jackwerth, et al.
Clinical and Translational Science|May 3, 2024
St. John's wort extract with a high hyperforin content does not induce P-glycoprotein activity at the human blood-brain barrierMyriam El Biali, Michael Wölfl-Duchek, Matthias Jackwerth, et al.
European Journal of Clinical Pharmacology|May 10, 2021
A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9Markus Zeitlinger, Martin Bauer, Roman Reindl-Schwaighofer, et al.
Clinical Pharmacology and Therapeutics|September 24, 2017
Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission TomographyMartin Bauer, Akihiro Matsuda, Beatrix Wulkersdorfer, et al.
Clinical Pharmacology and Therapeutics|September 6, 2006
A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's diseaseMartin Bauer, Oliver Langer, Peter Dal-Bianco, et al.
Frontiers in Immunology|October 8, 2025
Antiviral and immunomodulatory effect of zapnometinib in animal models and hospitalized COVID-19 patientsYvonne Füll, Lara M Schüssele, Hazem Hamza, et al.
Brain : a Journal of Neurology|November 29, 2011
Blood-brain barrier P-glycoprotein function in Alzheimer's diseaseDaniëlle M E van Assema, Mark Lubberink, Martin Bauer, et al.
The Lancet. Neurology|June 22, 2013
P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control studyMaria Feldmann, Marie-Claude Asselin, Joan Liu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 14, 2026
Continuous infusion [11C]-(+)-PHNO PET for measuring dopamine D2/3 receptor availability and amphetamine effects across the brain: Feasibility and test-retest reliabilityIrena Dajic, Ulrich Sauerzopf, Ana Weidenauer, et al.
Pageof 21